QA: Alimera Sciences INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001267602_2019_Alimera_Sciences_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest'}

Graph

Absolute values for 0001267602, Alimera Sciences INC

  xvar xval
0 AssetsCurrent 34,848,000
1 IntangibleAssetsNetIncludingGoodwill 16,723,000
2 PropertyPlantAndEquipmentNet 1,355,000
3 remainder_Assets 1,182,000
4 LiabilitiesCurrent 10,234,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,900,771
9 ResearchAndDevelopmentExpense 11,107,081
10 remainder_Expenses 35,801,826
11 remainder_Revenues 76,114,271
12 remainder_NetIncome -1,317,437
13 remainder_ComprehensiveNetIncome 36,495
  yvar yval
0 Assets 54,108,000
1 Liabilities 10,234,000
2 Expenses 61,809,678
3 Revenues 76,114,271
4 StockholdersEquity 43,874,000
5 NetIncome 12,987,156
6 ComprehensiveNetIncome 13,005,404
7 BaseVar 101,809,940
8 EconomicCapitalRatiobeforeLimitedLiability 3.38
9 EconomicCapitalRatio 3.94

Edgar->Model Mapping

Feature Distribution

Change over Time